JOURNAL OF CONTROLLED RELEASE | 卷:258 |
Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy | |
Article | |
Sun, Jingjing1  Liu, Yanhua2  Chen, Yichao1  Zhao, Wenchen1  Zhai, Qianyu3  Rathod, Sanjay1  Huang, Yixian1  Tang, Suoqin3  Kwon, Yong Tae1,4  Fernandez, Christian1  Venkataramanan, Raman1  Li, Song1  | |
[1] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA | |
[2] Ningxia Med Univ, Sch Pharm, Dept Pharmaceut, 1160 Shengli St, Yinchuan 750004, Peoples R China | |
[3] Gen Hosp Peoples Liberat Army, Dept Pediat, Beijing 100853, Peoples R China | |
[4] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Prot Metab Med Res Ctr, Seoul 110799, South Korea | |
关键词: Dasatinib; Prodrug micelles; Redox responsive; Doxorubicin; Co-delivery; | |
DOI : 10.1016/j.jconrel.2017.05.006 | |
来源: Elsevier | |
【 摘 要 】
Two novel prodrug polymers POEG-b-PSSDas (redox-sensitive) and POEG-b-PCCDas (redox-insensitive), which consist of poly(oligo(ethylene glycol) methacrylate) (POEG) hydrophilic blocks and dasatinib (DAS, an oncogenic tyrosine kinases inhibitor) conjugated hydrophobic blocks, were designed as dual-functional carriers for codelivery with doxorubicin (DOX). Both carriers retained antitumor activity of DAS and could form mixed micelles with DOX. Compared to POEG-b-PCCDas micelles, incorporation of disulfide linkage into POEG-bPSSDas micelles facilitated efficient cleavage of DAS from prodrug micelles in tumor cells/tissues, leading to a higher level of anti-tumor activity in vitro and in vivo. In addition, DOX-loaded POEG-b-PSSDas micelles exhibited triggered DOX release under a redox environment (10 mM glutathione, GSH), and demonstrated enhanced cytotoxicity against 4T1.2 and PC3 cell lines compared to DOX and DOX-loaded POEG-b-PCCDas micelles. More importantly, DOX-loaded POEG-b-PSSDas micelles were more effective in inhibiting the tumor growth and prolonging the survival rate in an aggressive murine breast cancer model (4T1.2) compared to DOXloaded POEG-b-PCCDas micelles and a micellar formulation co-loaded with DOX and DAS. This redox-responsive prodrug micellar system provides an attractive strategy for effective combination of tumor targeted therapy and traditional chemotherapy, which warrants further investigation.
【 授权许可】
Free
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
10_1016_j_jconrel_2017_05_006.pdf | 1400KB | download |